CRP and pulmonary arterial hypertension: Consistent with this, our clinical data showed elevated levels of the inflammatory marker C-reactive protein in the PAH group (PAH 0.65±0.73 vs. Control 0.22±0.28, p<0.001, see S1 and S2 Tables).